HealthLawProf Blog

Editor: Katharine Van Tassel
Akron Univ. School of Law

A Member of the Law Professor Blogs Network

Thursday, April 20, 2006

Psychiatrists, the DSM-IV, and Big Pharma

The New York Times reports today that more than half the psychiatrists who contributed to the canonical DSM-IV had financial connections to drug companies:

The percentage was higher — 100 percent in some cases — for experts who worked on sections of the manual devoted to severe mental illnesses, like schizophrenia, the study found. But the authors, from Tufts University and the University of Massachusetts, were not able to establish how many of the psychiatrists were receiving money from drug companies while the manual was being compiled.

Lisa Cosgrove, the study's lead author, who is a psychologist at the University of Massachusetts in Boston, said that although the study could not prove that the psychiatrists' ties influenced the manual's development, "what we're saying is it's outrageous that the manual doesn't have a disclosure policy."

But other experts scoffed at the idea that commercial interests had influenced either the language or content of the manual. "I can categorically say, and I was there every step of the way, that drug-company influence never entered into any of the discussions, whatsoever," said Dr. Michael First, a psychiatry professor at Columbia, who coordinated development of the current D.S.M.

Okay . . . I feel much better now.  [tm]

http://lawprofessors.typepad.com/healthlawprof_blog/2006/04/psychiatrists_t.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d834ba33db69e2

Listed below are links to weblogs that reference Psychiatrists, the DSM-IV, and Big Pharma:

Comments

Post a comment